Personal Mobility Devices Market (By Product: Walking Aids, Wheelchairs, Scooters) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Personal Mobility Devices Market 

5.1. COVID-19 Landscape: Personal Mobility Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Personal Mobility Devices Market, By Product

8.1. Personal Mobility Devices Market Revenue and Volume, by Product, 2024-2033

8.1.1. Walking Aids

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Wheelchairs

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Scooters

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Personal Mobility Devices Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.1.2. U.S.

9.1.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.1.3. Rest of North America

9.1.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.2. Europe

9.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.2.2. UK

9.2.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.2.3. Germany

9.2.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.2.4. France

9.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.2.5. Rest of Europe

9.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.3. APAC

9.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.3.2. India

9.3.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.3.3. China

9.3.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.3.4. Japan

9.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.3.5. Rest of APAC

9.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.4. MEA

9.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.4.2. GCC

9.4.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.4.3. North Africa

9.4.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.4.4. South Africa

9.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.4.5. Rest of MEA

9.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.5. Latin America

9.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.5.2. Brazil

9.5.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

9.5.3. Rest of LATAM

9.5.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

Chapter 10. Company Profiles

10.1. Invacare Corporation

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. Pride Mobility

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Kaye products

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Briggs Healthcare

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. Carex Health brand

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. GF Health products

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Ottobock

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Permobil

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. Electric mobility

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. Euroverma

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

PROCEED TO BUY :

   USD 5400
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample